Flagship Harbor Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Buy |
2,239
+110
| +5% | +$61.7K | 0.05% | 316 |
|
|
2026
Q1 | $1.2M | Sell |
2,129
-65
| -3% | -$41.7K | 0.05% | 287 |
|
|
2025
Q4 | $1.48M | Sell |
2,194
-203
| -8% | -$138K | 0.07% | 236 |
|
|
2025
Q3 | $1.53M | Sell |
2,397
-83
| -3% | -$50.4K | 0.07% | 248 |
|
|
2025
Q2 | $1.33M | Sell |
2,480
-506
| -17% | -$242K | 0.06% | 260 |
|
|
2025
Q1 | $1.25M | Sell |
2,986
-5
| -0.2% | -$2.17K | 0.07% | 248 |
|
|
2024
Q4 | $1.24M | Sell |
2,991
-2,073
| -41% | -$909K | 0.06% | 240 |
|
|
2024
Q3 | $2.56M | Sell |
5,064
-100
| -2% | -$48.6K | 0.14% | 142 |
|
|
2024
Q2 | $2.52M | Buy |
5,164
+1,506
| +41% | +$756K | 0.15% | 140 |
|
|
2024
Q1 | $1.98M | Buy |
3,658
+40
| +1% | +$21.9K | 0.13% | 156 |
|
|
2023
Q4 | $2.01M | Sell |
3,618
-158
| -4% | -$74.2K | 0.15% | 134 |
|
|
2023
Q3 | $1.65M | Buy |
3,776
+221
| +6% | +$110K | 0.14% | 151 |
|
|
2023
Q2 | $1.79M | Buy |
3,555
+122
| +4% | +$58.5K | 0.15% | 146 |
|
|
2023
Q1 | $1.72M | Sell |
3,433
-17
| -0.5% | -$8.13K | 0.16% | 150 |
|
|
2022
Q4 | $1.41M | Buy |
3,450
+100
| +3% | +$38.8K | 0.14% | 168 |
|
|
2022
Q3 | $1.09M | Sell |
3,350
-1,824
| -35% | -$670K | 0.13% | 181 |
|
|
2022
Q2 | $1.81M | Buy |
5,174
+880
| +20% | +$359K | 0.2% | 123 |
|
|
2022
Q1 | $2.35M | Buy |
4,294
+221
| +5% | +$116K | 0.23% | 110 |
|
|
2021
Q4 | $2.68M | Buy |
4,073
+984
| +32% | +$618K | 0.25% | 93 |
|
|
2021
Q3 | $1.95M | Hold |
3,089
| – | – | 0.21% | 112 |
|
|
2021
Q2 | $1.95M | Buy |
3,089
+115
| +4% | +$63.5K | 0.21% | 112 |
|
|
2021
Q1 | $1.46M | Buy |
2,974
+37
| +1% | +$18.5K | 0.17% | 139 |
|
|
2020
Q4 | $1.47M | Buy |
2,937
+88
| +3% | +$39.4K | 0.18% | 122 |
|
|
2020
Q3 | $1.12M | Buy |
2,849
+1,242
| +77% | +$459K | 0.15% | 132 |
|
|
2020
Q2 | $530K | Buy |
1,607
+104
| +7% | +$30.1K | 0.08% | 242 |
|
|
2020
Q1 | $364K | Sell |
1,503
-16
| -1% | -$4.18K | 0.07% | 260 |
|
|
2019
Q4 | $397K | Buy |
1,519
+20
| +1% | +$5.27K | 0.07% | 277 |
|
|
2019
Q3 | $407K | Buy |
1,499
+2
| +0.1% | +$557 | 0.08% | 250 |
|
|
2019
Q2 | $412K | Hold |
1,497
| – | – | 0.09% | 244 |
|
|
2019
Q1 | $334K | Buy |
1,497
+38
| +3% | +$7.84K | 0.07% | 285 |
|
|
2018
Q4 | $271K | Sell |
1,459
-44
| -3% | -$9.02K | 0.07% | 288 |
|
|
2018
Q3 | $374K | Sell |
1,503
-48
| -3% | -$11.7K | 0.07% | 275 |
|
|
2018
Q2 | $338K | Sell |
1,551
-76
| -5% | -$15.7K | 0.07% | 274 |
|
|
2018
Q1 | $305K | Sell |
1,627
-61
| -4% | -$11.3K | 0.09% | 239 |
|
|
2017
Q4 | $277K | Sell |
1,688
-12
| -0.7% | -$1.89K | 0.08% | 270 |
|
|
2017
Q3 | $267K | Buy |
1,700
+188
| +12% | +$29.7K | 0.09% | 257 |
|
|
2017
Q2 | $243K | Buy |
1,512
+216
| +17% | +$35.1K | 0.08% | 275 |
|
|
2017
Q1 | $200K | Buy |
+1,296
| New | +$179K | 0.08% | 303 |
|
Other funds holding IDXX
Flagship Harbor Advisors's IDXX Position: Q2 2026 in Review
Flagship Harbor Advisors increased its Idexx Laboratories (IDXX) stake by 5.2% in Q2 2026, buying an estimated $61.7K and bringing the position to 2,239 shares worth $1.18M. The position accounts for 0.05% of the portfolio, ranked #316.
Flagship Harbor Advisors first reported a position in IDXX in Q1 2017 and has held it in 38 quarters since. The position peaked at $2.68M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Flagship Harbor Advisors held 2,239 shares of Idexx Laboratories worth $1.18M as of Q2 2026.
- Flagship Harbor Advisors bought 110 Idexx Laboratories shares in Q2 2026, an estimated $61.7K.
- Idexx Laboratories made up 0.05% of Flagship Harbor Advisors's portfolio in Q2 2026, its #316 holding.
- Flagship Harbor Advisors first reported a position in Idexx Laboratories in Q1 2017 and has held it in 38 quarters since.
- Flagship Harbor Advisors's Idexx Laboratories position peaked at $2.68M in Q4 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.